Schizophrenia Bulletin, ISSN 0586-7614, 3/2009, Volume 35, Issue 2, pp. 458 - 468
In patients with schizophrenia who do not have an optimal response to clozapine, it remains unclear if there is an evidence base to support a second...
Schizophrenia | Combination strategies | Clozapine | QUALITY | AUGMENTATION | RANDOMIZED-TRIALS | REFRACTORY SCHIZOPHRENIA | PSYCHIATRY | STATISTICS NOTES | METAANALYSES | RISPERIDONE | schizophrenia | combination strategies | CLINICAL-TRIALS | DOUBLE-BLIND | clozapine | PLACEBO-CONTROLLED TRIAL | Clozapine - therapeutic use | Double-Blind Method | Antipsychotic Agents - therapeutic use | Humans | Treatment Outcome | Schizophrenia - drug therapy | Drug Therapy, Combination | Schizophrenic Psychology | Databases as Topic | Randomized Controlled Trials as Topic | Regular
Schizophrenia | Combination strategies | Clozapine | QUALITY | AUGMENTATION | RANDOMIZED-TRIALS | REFRACTORY SCHIZOPHRENIA | PSYCHIATRY | STATISTICS NOTES | METAANALYSES | RISPERIDONE | schizophrenia | combination strategies | CLINICAL-TRIALS | DOUBLE-BLIND | clozapine | PLACEBO-CONTROLLED TRIAL | Clozapine - therapeutic use | Double-Blind Method | Antipsychotic Agents - therapeutic use | Humans | Treatment Outcome | Schizophrenia - drug therapy | Drug Therapy, Combination | Schizophrenic Psychology | Databases as Topic | Randomized Controlled Trials as Topic | Regular
Journal Article
Music and Medicine, ISSN 1943-8621, 10/2013, Volume 5, Issue 4, pp. 223 - 227
Despite their social deficits and behavioral abnormalities, individuals with autism may frequently display unexpected and unusual areas of interest and...
Journal Article
Psychomusicology, ISSN 0275-3987, 06/2013, Volume 23, Issue 2, pp. 109 - 116
Although researchers have investigated absolute pitch and musical memory in individuals with co-occurring autism, congenital blindness, and exceptional musical...
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2018, Volume 13, Issue 8, p. e0201371
Background For many years, long-acting intramuscular (LAI) antipsychotics have been prescribed predominantly to chronic and severe patients, as a last resort...
1ST EPISODE | COMPARATIVE EFFICACY | NEGATIVE SYMPTOMS | MULTIDISCIPLINARY SCIENCES | INJECTABLE ANTIPSYCHOTICS | SCHIZOPHRENIA | DEPOT ANTIPSYCHOTICS | INJECTIONS | PATIENT | ORAL ANTIPSYCHOTICS | ATTITUDES | Schizophrenia | Bipolar disorder | Usage | Care and treatment | Prescription writing | Antipsychotic drugs | Health sciences | Neurosciences | Substance abuse treatment | Neuroleptics | Mental disorders | Comorbidity | Mental health | Systematic review | Regression analysis | Aripiprazole | Males | Metabolism | Patients | Training | Psychotropic drugs | Hospitals | Maternal & child health | Surgery | Diagnosis | Risperidone | Psychiatry | Drug use
1ST EPISODE | COMPARATIVE EFFICACY | NEGATIVE SYMPTOMS | MULTIDISCIPLINARY SCIENCES | INJECTABLE ANTIPSYCHOTICS | SCHIZOPHRENIA | DEPOT ANTIPSYCHOTICS | INJECTIONS | PATIENT | ORAL ANTIPSYCHOTICS | ATTITUDES | Schizophrenia | Bipolar disorder | Usage | Care and treatment | Prescription writing | Antipsychotic drugs | Health sciences | Neurosciences | Substance abuse treatment | Neuroleptics | Mental disorders | Comorbidity | Mental health | Systematic review | Regression analysis | Aripiprazole | Males | Metabolism | Patients | Training | Psychotropic drugs | Hospitals | Maternal & child health | Surgery | Diagnosis | Risperidone | Psychiatry | Drug use
Journal Article
BMC Psychiatry, ISSN 1471-244X, 08/2013, Volume 13, Issue 1, pp. 212 - 212
Background: Data on therapeutic interventions following deliberate self harm (DSH) in patients with treatment-resistant depression (TRD) are very scant and...
Antidepressant | Deliberate self harm | Mortality | Randomised controlled trial | Treatment resistant | Depression | Lithium | Suicide | OUTPATIENTS | PSYCHIATRY | BEHAVIOR | PREVENTION | DISORDERS | DELIBERATE SELF-HARM | MAJOR DEPRESSION | STRATEGIES | CONSORT STATEMENT | Antimanic Agents - therapeutic use | Humans | Middle Aged | Clinical Protocols | Male | Risk | Treatment Outcome | Depressive Disorder, Treatment-Resistant - drug therapy | Antidepressive Agents - therapeutic use | Lithium - therapeutic use | Adult | Female | Self-Injurious Behavior | Research Design | Suicidal behavior | Mediation | Depression, Mental | Blindness | Antidepressants, Tricyclic
Antidepressant | Deliberate self harm | Mortality | Randomised controlled trial | Treatment resistant | Depression | Lithium | Suicide | OUTPATIENTS | PSYCHIATRY | BEHAVIOR | PREVENTION | DISORDERS | DELIBERATE SELF-HARM | MAJOR DEPRESSION | STRATEGIES | CONSORT STATEMENT | Antimanic Agents - therapeutic use | Humans | Middle Aged | Clinical Protocols | Male | Risk | Treatment Outcome | Depressive Disorder, Treatment-Resistant - drug therapy | Antidepressive Agents - therapeutic use | Lithium - therapeutic use | Adult | Female | Self-Injurious Behavior | Research Design | Suicidal behavior | Mediation | Depression, Mental | Blindness | Antidepressants, Tricyclic
Journal Article
BMC research notes, ISSN 1756-0500, 2014, Volume 7, Issue 1, p. 731
As lithium treatment might be effective in reducing the risk of deliberate self-harm (DSH) in adult patients with unipolar affective disorders, we designed a...
Lithium | Deliberate self harm | Treatment resistant depression | Suicide | Mortality | Randomised controlled trial | Humans | Suicide - prevention & control | Male | Suicidal Ideation | Depression - drug therapy | Psychiatric Status Rating Scales | Time Factors | Antipsychotic Agents - therapeutic use | Suicide - psychology | Adult | Female | Drug Therapy, Combination | Severity of Illness Index | Affect - drug effects | Antimanic Agents - therapeutic use | Kaplan-Meier Estimate | Treatment Outcome | Antidepressive Agents - therapeutic use | Depression - diagnosis | Depression - mortality | Sample Size | Lithium Compounds - therapeutic use | Depression - psychology | Italy | Research Design | Confidence intervals | Suicides & suicide attempts
Lithium | Deliberate self harm | Treatment resistant depression | Suicide | Mortality | Randomised controlled trial | Humans | Suicide - prevention & control | Male | Suicidal Ideation | Depression - drug therapy | Psychiatric Status Rating Scales | Time Factors | Antipsychotic Agents - therapeutic use | Suicide - psychology | Adult | Female | Drug Therapy, Combination | Severity of Illness Index | Affect - drug effects | Antimanic Agents - therapeutic use | Kaplan-Meier Estimate | Treatment Outcome | Antidepressive Agents - therapeutic use | Depression - diagnosis | Depression - mortality | Sample Size | Lithium Compounds - therapeutic use | Depression - psychology | Italy | Research Design | Confidence intervals | Suicides & suicide attempts
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2009, Issue 3, pp. CD006324 - CD006324
Background Although clozapine has been shown to be the treatment of choice in people with schizophrenia that are resistant to treatment, one third to two...
TRIALS | MEDICINE, GENERAL & INTERNAL | AUGMENTATION STRATEGIES | EFFICACY | HALOPERIDOL | STATISTICS NOTES | TOLERABILITY | DOUBLE-BLIND | RISPERIDONE | OLANZAPINE | RATING-SCALE | Clozapine - therapeutic use | Sulpiride - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Quetiapine Fumarate | Male | Piperazines - therapeutic use | Thiazoles - therapeutic use | Randomized Controlled Trials as Topic | Sulpiride - analogs & derivatives | Dibenzothiazepines - therapeutic use | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Female | Schizophrenia - drug therapy | Clozapine - adverse effects | Drug Therapy, Combination | Drug Resistance | Index Medicus
TRIALS | MEDICINE, GENERAL & INTERNAL | AUGMENTATION STRATEGIES | EFFICACY | HALOPERIDOL | STATISTICS NOTES | TOLERABILITY | DOUBLE-BLIND | RISPERIDONE | OLANZAPINE | RATING-SCALE | Clozapine - therapeutic use | Sulpiride - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Quetiapine Fumarate | Male | Piperazines - therapeutic use | Thiazoles - therapeutic use | Randomized Controlled Trials as Topic | Sulpiride - analogs & derivatives | Dibenzothiazepines - therapeutic use | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Female | Schizophrenia - drug therapy | Clozapine - adverse effects | Drug Therapy, Combination | Drug Resistance | Index Medicus
Journal Article
Functional Neurology, ISSN 0393-5264, 10/2006, Volume 21, Issue 4, pp. 187 - 191
Music, a universal art form that exists in every culture around the world, is integral to a number of social and courtship activities, and is closely...
Electrophysiology | Neuroimaging neurology | Psychiatry | Music | Music therapy | BRAIN-REGIONS | LANGUAGE | SYSTEM | BEHAVIOR | psychiatry | music therapy | neuroimaging neurology | INVESTIGATING EMOTION | NEUROSCIENCES | RESPONSES | music | SEIZURES | THERAPY | SONG | electrophysiology | CORRELATE | Emotions - physiology | Seizures - physiopathology | Brain - anatomy & histology | Humans | Nervous System Physiological Phenomena | Music Therapy | Perception | Music - psychology | Brain - physiology
Electrophysiology | Neuroimaging neurology | Psychiatry | Music | Music therapy | BRAIN-REGIONS | LANGUAGE | SYSTEM | BEHAVIOR | psychiatry | music therapy | neuroimaging neurology | INVESTIGATING EMOTION | NEUROSCIENCES | RESPONSES | music | SEIZURES | THERAPY | SONG | electrophysiology | CORRELATE | Emotions - physiology | Seizures - physiopathology | Brain - anatomy & histology | Humans | Nervous System Physiological Phenomena | Music Therapy | Perception | Music - psychology | Brain - physiology
Journal Article
Neuroscience Letters, ISSN 0304-3940, 2010, Volume 471, Issue 3, pp. 162 - 165
The objective of this study was to examine whether levels of endotoxin and other markers of immuno-inflammatory activation are altered in adult patients with...
Autism | Vineland Adaptive Behavior Scales | Inflammation | Endotoxin | Immunity | Socialization | SCD14 | SPECTRUM DISORDERS | NEURODEGENERATION | NEUROSCIENCES | CHILDREN | NEUROINFLAMMATION | DISEASE | BRAIN | INNATE IMMUNITY | Endotoxins - blood | Severity of Illness Index | Humans | Autistic Disorder - blood | Autistic Disorder - immunology | Interleukin-10 - blood | Male | Immunity, Innate | Interleukin-1beta - blood | Lipopolysaccharide Receptors - blood | Young Adult | Endotoxemia - complications | Interleukin-6 - blood | Social Behavior | Adolescent | Endotoxemia - immunology | Adult | Female | Endotoxemia - blood | Autistic Disorder - complications | Care and treatment | Social aspects | Musicians
Autism | Vineland Adaptive Behavior Scales | Inflammation | Endotoxin | Immunity | Socialization | SCD14 | SPECTRUM DISORDERS | NEURODEGENERATION | NEUROSCIENCES | CHILDREN | NEUROINFLAMMATION | DISEASE | BRAIN | INNATE IMMUNITY | Endotoxins - blood | Severity of Illness Index | Humans | Autistic Disorder - blood | Autistic Disorder - immunology | Interleukin-10 - blood | Male | Immunity, Innate | Interleukin-1beta - blood | Lipopolysaccharide Receptors - blood | Young Adult | Endotoxemia - complications | Interleukin-6 - blood | Social Behavior | Adolescent | Endotoxemia - immunology | Adult | Female | Endotoxemia - blood | Autistic Disorder - complications | Care and treatment | Social aspects | Musicians
Journal Article
Journal of Alternative and Complementary Medicine, ISSN 1075-5535, 09/2007, Volume 13, Issue 7, pp. 709 - 712
Background: Data on the potential behavioral effects of music therapy in autism are scarce. Objective: The aim of this study was to investigate whether a...
CHILDHOOD AUTISM | PSYCHIATRY | INTEGRATIVE & COMPLEMENTARY MEDICINE | RATING-SCALE CARS | CHILDREN | Psychomotor Performance | Outcome Assessment (Health Care) | Developmental Disabilities - etiology | Humans | Developmental Disabilities - therapy | Rehabilitation Centers | Brief Psychiatric Rating Scale | Cognition Disorders - etiology | Music | Adolescent | Music Therapy - methods | Quality of Life | Adult | Italy | Cognition Disorders - therapy | Autistic Disorder - complications | Autistic Disorder - therapy
CHILDHOOD AUTISM | PSYCHIATRY | INTEGRATIVE & COMPLEMENTARY MEDICINE | RATING-SCALE CARS | CHILDREN | Psychomotor Performance | Outcome Assessment (Health Care) | Developmental Disabilities - etiology | Humans | Developmental Disabilities - therapy | Rehabilitation Centers | Brief Psychiatric Rating Scale | Cognition Disorders - etiology | Music | Adolescent | Music Therapy - methods | Quality of Life | Adult | Italy | Cognition Disorders - therapy | Autistic Disorder - complications | Autistic Disorder - therapy
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 07/2009, Volume 1169, Issue 1, pp. 332 - 335
As a consequence of frequent limbic alterations, autistic persons could judge pleasant and unpleasant music in an unusual manner. We explored this possibility...
limbic system | music | emotions | autistic disorder | Autism | Musicians
limbic system | music | emotions | autistic disorder | Autism | Musicians
Journal Article
Functional Neurology, ISSN 0393-5264, 01/2010, Volume 25, Issue 1, pp. 15 - 20
Mental processing is the product of the huge number of synaptic interactions that occur in the brain. It is easier to understand how brain functions can...
Autism | ASD | Brain connectivity | Cerebro-cerebellar loops | Music | SAVANT | INFORMATION | SPECTRUM DISORDERS | NEUROSCIENCES | autism | CHILDREN | brain connectivity | music | THERAPY | CEREBELLUM | SYSTEMS | cerebro-cerebellar loops | EXPERIENCE | DIRECTIONS | Emotions - physiology | Humanities - psychology | Autistic Disorder - pathology | Animals | Brain - physiopathology | Cognition Disorders - etiology | Humans | Neural Pathways - physiopathology | Autistic Disorder - complications
Autism | ASD | Brain connectivity | Cerebro-cerebellar loops | Music | SAVANT | INFORMATION | SPECTRUM DISORDERS | NEUROSCIENCES | autism | CHILDREN | brain connectivity | music | THERAPY | CEREBELLUM | SYSTEMS | cerebro-cerebellar loops | EXPERIENCE | DIRECTIONS | Emotions - physiology | Humanities - psychology | Autistic Disorder - pathology | Animals | Brain - physiopathology | Cognition Disorders - etiology | Humans | Neural Pathways - physiopathology | Autistic Disorder - complications
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 07/2009, Volume 1169, Issue 1, pp. 332 - 335
As a consequence of frequent limbic alterations, autistic persons could judge pleasant and unpleasant music in an unusual manner. We explored this possibility...
limbic system | music | emotions | autistic disorder | Limbic system | Autistic disorder | Music | Emotions | DISSONANCE | MULTIDISCIPLINARY SCIENCES | INFANTS | DISORDERS | MONKEYS | CONSONANCE | Autistic Disorder - physiopathology | Humans | Adult | Female | Male | Autistic Disorder - psychology
limbic system | music | emotions | autistic disorder | Limbic system | Autistic disorder | Music | Emotions | DISSONANCE | MULTIDISCIPLINARY SCIENCES | INFANTS | DISORDERS | MONKEYS | CONSONANCE | Autistic Disorder - physiopathology | Humans | Adult | Female | Male | Autistic Disorder - psychology
Journal Article
Progress in Neuropsychopharmacology & Biological Psychiatry, ISSN 0278-5846, 2010, Volume 34, Issue 4, pp. 681 - 683
High mobility group box 1 (HMGB1) is a highly conserved, ubiquitous protein that functions as an activator for inducing the immune response and can be released...
High mobility group box 1 | Inflammation | Social interaction | Autism spectrum disorder | High mobility group box 1 | ACTIVATION | PSYCHIATRY | RECEPTOR | HMGB1 | RELEASE | ASTROCYTES | NEUROSCIENCES | CLINICAL NEUROLOGY | NEUROINFLAMMATION | ROLES | PHARMACOLOGY & PHARMACY | DYSFUNCTION | AGE-RAGE | BRAIN | Enzyme-Linked Immunosorbent Assay | Humans | Adolescent | Autistic Disorder - blood | Adult | Female | Male | Chi-Square Distribution | HMGB1 Protein - blood | Autism | Care and treatment | Chromosomal proteins | Social aspects | Glutamate | Musicians | Enzyme-linked immunosorbent assay
High mobility group box 1 | Inflammation | Social interaction | Autism spectrum disorder | High mobility group box 1 | ACTIVATION | PSYCHIATRY | RECEPTOR | HMGB1 | RELEASE | ASTROCYTES | NEUROSCIENCES | CLINICAL NEUROLOGY | NEUROINFLAMMATION | ROLES | PHARMACOLOGY & PHARMACY | DYSFUNCTION | AGE-RAGE | BRAIN | Enzyme-Linked Immunosorbent Assay | Humans | Adolescent | Autistic Disorder - blood | Adult | Female | Male | Chi-Square Distribution | HMGB1 Protein - blood | Autism | Care and treatment | Chromosomal proteins | Social aspects | Glutamate | Musicians | Enzyme-linked immunosorbent assay
Journal Article
Psychomusicology: Music, Mind, and Brain, ISSN 0275-3987, 6/2013, Volume 23, Issue 2, pp. 109 - 116
Although researchers have investigated absolute pitch and musical memory in individuals with co-occurring autism, congenital blindness, and exceptional musical...
Journal Article
16.
Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia
Neuroendocrinology Letters, ISSN 0172-780X, 2010, Volume 31, Issue 1, pp. 117 - 121
OBJECTIVE: Previous studies have suggested that the endogeneous psychotomimetic molecule bufotenine (N-N-dimethyl-5-idroxytryptamine) may play a role in the...
Schizophrenia | Autism | Bufotenine | High-performance liquid chromatography-mass spectrometry | INDOLEAMINES | 5-HYDROXYTRYPTAMINE | EARLY INFANTILE AUTISM | high-performance liquid chromatography-mass spectrometry | ENDOCRINOLOGY & METABOLISM | PSYCHIATRIC-DISORDERS | bufotenine | schizophrenia | NEUROSCIENCES | autism | BRAIN | Up-Regulation | Schizophrenia - urine | Humans | Male | Chromatography, High Pressure Liquid | Bufotenin - analysis | Case-Control Studies | Young Adult | Brief Psychiatric Rating Scale | Mass Spectrometry | Adult | Female | Bufotenin - urine | Research Design | Autistic Disorder - urine
Schizophrenia | Autism | Bufotenine | High-performance liquid chromatography-mass spectrometry | INDOLEAMINES | 5-HYDROXYTRYPTAMINE | EARLY INFANTILE AUTISM | high-performance liquid chromatography-mass spectrometry | ENDOCRINOLOGY & METABOLISM | PSYCHIATRIC-DISORDERS | bufotenine | schizophrenia | NEUROSCIENCES | autism | BRAIN | Up-Regulation | Schizophrenia - urine | Humans | Male | Chromatography, High Pressure Liquid | Bufotenin - analysis | Case-Control Studies | Young Adult | Brief Psychiatric Rating Scale | Mass Spectrometry | Adult | Female | Bufotenin - urine | Research Design | Autistic Disorder - urine
Journal Article
Music & Medicine, ISSN 1943-8621, 2013, Volume 5, Issue 4, pp. 223 - 227
Journal Article
Neuroscience Letters, ISSN 0304-3940, 2006, Volume 410, Issue 3, pp. 169 - 173
An excess accumulation of advanced glycation end products (AGEs) has been reported in autism brains. Through their interaction with their putative receptor...
Autistic spectrum disorders | Oxidative stress | Advanced glycation end products | Calgranulins | ELISA | SPECTRUM DISORDERS | RECEPTOR | autistic spectrum disorders | calgranulins | advanced glycation end products | NEUROSCIENCES | CHILDREN | VASCULAR COMPLICATIONS | ENDOTHELIAL-CELLS | SERUM-LEVELS | PROTEINS | oxidative stress | BRAIN | GLYCATION END-PRODUCTS | Severity of Illness Index | Calgranulin B - metabolism | Autistic Disorder - metabolism | Glycation End Products, Advanced - metabolism | Humans | Adult | Female | Male | Statistics as Topic | Case-Control Studies | Autism | Cardiac patients
Autistic spectrum disorders | Oxidative stress | Advanced glycation end products | Calgranulins | ELISA | SPECTRUM DISORDERS | RECEPTOR | autistic spectrum disorders | calgranulins | advanced glycation end products | NEUROSCIENCES | CHILDREN | VASCULAR COMPLICATIONS | ENDOTHELIAL-CELLS | SERUM-LEVELS | PROTEINS | oxidative stress | BRAIN | GLYCATION END-PRODUCTS | Severity of Illness Index | Calgranulin B - metabolism | Autistic Disorder - metabolism | Glycation End Products, Advanced - metabolism | Humans | Adult | Female | Male | Statistics as Topic | Case-Control Studies | Autism | Cardiac patients
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 06/2011, Volume 31, Issue 3, pp. 266 - 273
Journal Article